Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wallach

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
JAMA|June 22, 2002
Osteopontin as a biomarker for ovarian cancerRobert C Wallach
Gynecologic Oncology|August 12, 1998
High frequency of BRCA1 and BRCA2 mutations in Ashkenazi Jewish ovarian cancer patientsR C Wallach
JAMA|August 23, 1995
What component of prenatal care is responsible for improved outcome?R C Wallach
The New England Journal of Medicine|April 9, 2005
Post-call accidentsRobert C Wallach
Obstetrics and Gynecology|February 23, 2016
Disseminated Intravascular Coagulation Syndromes in ObstetricsRobert C Wallach
Clinics in Dermatology|April 1, 1987
Inflammatory and neoplastic diseases of the vulvaR C Wallach
Gynecologic Oncology|June 1, 2000
Re: Ashih et al.: Cost effectiveness of treatment of early endometrial cancer. Gynecol Oncol 74:208-216, 1999R C Wallach
Gynecologic Oncology|February 1, 2008
Re: Venous thromboembolism prophylaxisRobert C Wallach
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1976
Calcified myoma of utero-ovarian ligament in a pubertal girlR C Wallach
Oncology (Williston Park, N.Y.)|January 13, 2009
Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusionRobert C Wallach
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
JAMA|June 22, 2002
Osteopontin as a biomarker for ovarian cancerRobert C Wallach
Gynecologic Oncology|August 12, 1998
High frequency of BRCA1 and BRCA2 mutations in Ashkenazi Jewish ovarian cancer patientsR C Wallach
JAMA|August 23, 1995
What component of prenatal care is responsible for improved outcome?R C Wallach
The New England Journal of Medicine|April 9, 2005
Post-call accidentsRobert C Wallach
Obstetrics and Gynecology|February 23, 2016
Disseminated Intravascular Coagulation Syndromes in ObstetricsRobert C Wallach
Clinics in Dermatology|April 1, 1987
Inflammatory and neoplastic diseases of the vulvaR C Wallach
Gynecologic Oncology|June 1, 2000
Re: Ashih et al.: Cost effectiveness of treatment of early endometrial cancer. Gynecol Oncol 74:208-216, 1999R C Wallach
Gynecologic Oncology|February 1, 2008
Re: Venous thromboembolism prophylaxisRobert C Wallach
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1976
Calcified myoma of utero-ovarian ligament in a pubertal girlR C Wallach
Oncology (Williston Park, N.Y.)|January 13, 2009
Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusionRobert C Wallach
Pageof 10